Literature DB >> 23597607

A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarction.

Marije M Vis1, Marcel A Beijk, Maik J Grundeken, Jan Baan, Karel T Koch, Joanna J Wykrzykowska, E Karin Arkenbout, Jan G P Tijssen, Robbert J de Winter, Jan J Piek, José P S Henriques.   

Abstract

OBJECTIVES: This study sought to evaluate 30-day all-cause mortality of patients treated with primary percutaneous coronary intervention (PCI) presenting with an acute myocardial infarction (AMI) due to an unprotected left main coronary artery (ULMCA) culprit lesion. In addition, an average estimated mortality rate was extrapolated from the available data.
BACKGROUND: There are limited data available on clinical outcome after primary PCI in patients presenting with AMI with unprotected left main as the infarct-related coronary artery.
METHODS: Medical literature databases were searched to identify cohort studies reporting on primary PCI for unprotected left main-related AMI. A total of 13 retrospective studies meeting all pre-specified criteria were included in the meta-analysis. No randomized trials were available. The primary endpoint for the meta-analysis was 30-day all-cause mortality.
RESULTS: This meta-analysis comprises a total of 977 patients, of which 252 (26%) presented in cardiogenic shock. Thirty-day all-cause mortality was evaluated using a forest plot analysis and showed higher event rates in patients presenting with cardiogenic shock among all subgroups. The average estimated 30-day all-cause mortality was 15% in patients presenting without signs of cardiogenic shock and 55% in patients presenting with cardiogenic shock (relative risk: 3.74, 95% confidence interval [CI]: 2.95 to 4.76, p < 0.001).
CONCLUSIONS: In this large meta-analysis of patients treated with primary PCI for AMI due to an ULMCA culprit lesion, the 30-day all-cause mortality in patients presenting with shock is much higher than in patients not presenting with shock. The estimated all-cause mortality data may serve as a benchmark for future reference.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23597607     DOI: 10.1016/j.jcin.2012.10.020

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  16 in total

1.  Long-term prognosis of patients with acute myocardial infarction due to unprotected left main coronary artery disease: a single-centre experience over 14 years.

Authors:  Li Xu; Hao Sun; Le-Feng Wang; Xin-Chun Yang; Kui-Bao Li; Da-Peng Zhang; Hong-Shi Wang; Wei-Ming Li
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

2.  The Role of the Transradial Approach for Complex Coronary Interventions in Patients with Acute Coronary Syndrome.

Authors:  Sasko Kedev
Journal:  Interv Cardiol       Date:  2013-08

3.  Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.

Authors:  Georg Fuernau; Karl Fengler; Steffen Desch; Ingo Eitel; Franz-Josef Neumann; Hans-Georg Olbrich; Antoinette de Waha; Suzanne de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Rainer Hambrecht; Christian Jung; Michael Böhm; Janine Pöss; Ruth H Strasser; Steffen Schneider; Taoufik Ouarrak; Gerhard Schuler; Karl Werdan; Uwe Zeymer; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2016-07-04       Impact factor: 5.460

4.  Circulating miR-182-5p and miR-5187-5p as biomarkers for the diagnosis of unprotected left main coronary artery disease.

Authors:  Lingping Zhu; Tong Chen; Wenrui Ye; Jun-Yao Wang; Ji-Peng Zhou; Zhen-Yu Li; Chuan-Chang Li
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

Review 5.  Management of ST-Elevation Myocardial Infarction in High-Risk Settings.

Authors:  Mohamed A Omer; Jose E Exaire; Jacob C Jentzer; Yader B Sandoval; Mandeep Singh; Charles R Cagin; Islam Y Elgendy; Tahir Tak
Journal:  Int J Angiol       Date:  2021-02-12

6.  Thirty Years Later: Evolution of Treatment for Acute Left Main Coronary Artery Occlusion.

Authors:  Moshe Y Flugelman; Nissan Ben-Dov; Basheer Karkabi; Ronen Jaffe
Journal:  Case Rep Cardiol       Date:  2016-12-19

7.  Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion (OPTIMAL): study protocol for a randomised controlled trial.

Authors:  Yang Gao; Feng Zhang; Chenguang Li; Yuxiang Dai; Ji'e Yang; Ya'nan Qu; Juying Qian; Junbo Ge
Journal:  Trials       Date:  2019-03-08       Impact factor: 2.279

Review 8.  Treatment strategies in the left main coronary artery disease associated with acute coronary syndromes.

Authors:  Ahmet Karabulut; Mahmut Cakmak
Journal:  J Saudi Heart Assoc       Date:  2015-03-21

9.  One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.

Authors:  Hai-Wei Liu; Ya-Ling Han; Quan-Min Jin; Xiao-Zeng Wang; Ying-Yan Ma; Geng Wang; Bin Wang; Kai Xu; Yi Li; Shao-Liang Chen
Journal:  Chin Med J (Engl)       Date:  2018-06-20       Impact factor: 2.628

10.  When the situation almost cannot be worse….

Authors:  Petr Hájek; Radka Adlová; Josef Veselka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-09-21       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.